ReShape Lifesciences Inc. (NASDAQ: RSLS)
$0.24
+0.0073 ( +3.21% ) 876.7K
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Market Data
Open
$0.24
Previous close
$0.23
Volume
876.7K
Market cap
$5.49M
Day range
$0.21 - $0.24
52 week range
$0.14 - $1.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 21 | Jul 09, 2024 |
8-k | 8K-related | 16 | May 20, 2024 |
10-q | Quarterly Reports | 60 | May 15, 2024 |
8-k | 8K-related | 13 | Apr 10, 2024 |
8-k | 8K-related | 15 | Apr 10, 2024 |
8-k | 8K-related | 15 | Apr 04, 2024 |
10-k | Annual reports | 88 | Apr 01, 2024 |
8-k | 8K-related | 14 | Feb 26, 2024 |
def | Proxies and info statements | 6 | Jan 24, 2024 |
8-k | 8K-related | 13 | Jan 18, 2024 |